Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Erik Hellstrom

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|February 26, 2003
Therapeutic vaccination with tumor cells that engage CD137Karl Erik Hellstrom, Ingegerd Hellstrom
Progress in Molecular Biology and Translational Science|August 7, 2019
From the Hellstrom paradox toward cancer cureKarl Erik Hellstrom, Ingegerd Hellstrom
Journal of Cellular Biochemistry|August 31, 2007
Vaccines to treat cancer--an old approach whose time has arrivedKarl Erik Hellstrom, Ingegerd Hellstrom
Expert Review of Vaccines|January 9, 2004
Novel approaches to therapeutic cancer vaccinesKarl Erik Hellstrom, Ingegerd Hellstrom
Expert Opinion on Medical Diagnostics|June 7, 2011
fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinomaIngegerd Hellstrom, Karl Erik Hellstrom
Advances in Experimental Medicine and Biology|June 13, 2008
SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each otherIngegerd Hellstrom, Karl Erik Hellstrom
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2015
Immune Mechanisms Are Major Players in CancerKarl Erik Hellstrom, Ingegerd Hellstrom
Human Antibodies|January 14, 2017
Curing tumor-bearing mice by shifting a Th2 to a Th1 anti-tumor responseKarl Erik Hellstrom, Min Dai, Ingegerd Hellstrom
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Administration of cyclophosphamide changes the immune profile of tumor-bearing micePu Liu, Jade Jaffar, Ingegerd Hellstrom, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2016
An In Vitro Model That Predicts the Therapeutic Efficacy of Immunomodulatory AntibodiesMin Dai, Yuen Yee Yip, Ingegerd Hellstrom, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Molecular Medicine (Berlin, Germany)|February 26, 2003
Therapeutic vaccination with tumor cells that engage CD137Karl Erik Hellstrom, Ingegerd Hellstrom
Progress in Molecular Biology and Translational Science|August 7, 2019
From the Hellstrom paradox toward cancer cureKarl Erik Hellstrom, Ingegerd Hellstrom
Journal of Cellular Biochemistry|August 31, 2007
Vaccines to treat cancer--an old approach whose time has arrivedKarl Erik Hellstrom, Ingegerd Hellstrom
Expert Review of Vaccines|January 9, 2004
Novel approaches to therapeutic cancer vaccinesKarl Erik Hellstrom, Ingegerd Hellstrom
Expert Opinion on Medical Diagnostics|June 7, 2011
fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinomaIngegerd Hellstrom, Karl Erik Hellstrom
Advances in Experimental Medicine and Biology|June 13, 2008
SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each otherIngegerd Hellstrom, Karl Erik Hellstrom
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2015
Immune Mechanisms Are Major Players in CancerKarl Erik Hellstrom, Ingegerd Hellstrom
Human Antibodies|January 14, 2017
Curing tumor-bearing mice by shifting a Th2 to a Th1 anti-tumor responseKarl Erik Hellstrom, Min Dai, Ingegerd Hellstrom
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Administration of cyclophosphamide changes the immune profile of tumor-bearing micePu Liu, Jade Jaffar, Ingegerd Hellstrom, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2016
An In Vitro Model That Predicts the Therapeutic Efficacy of Immunomodulatory AntibodiesMin Dai, Yuen Yee Yip, Ingegerd Hellstrom, et al.
Pageof 4